iData’s U.S. neurology devices market MedSuite covers 14 markets and COVID-19 impacts. The MedSuite is a compilation of all reports related to a specific market. It is ideal for device manufacturers, product managers, marketing managers, and consultants looking for a detailed analysis of every market segment and sub-segment within a given market.

In 2020, the global neuromodulation device market size was valued at nearly $4.4 billion, with over 230,000 neuromodulation procedures performed every year. The neuromodulation devices market growth is expected to be around 7.6% allowing the market size to approach $7.3 billion in 2026. Throughout this medical market research, we analyzed 13 neuromodulation device companies across

iData’s U.S. spinal implants market MedSuite covers 8 markets including procedure numbers and COVID-19 impacts. The MedSuite is a compilation of all reports related to a specific market. It is ideal for device manufacturers, product managers, marketing managers, and consultants looking for a detailed analysis of every market segment and sub-segment within a given market.

iData’s U.S. Surgical Robotics MedSuite covers 12 markets including the neurosurgery navigation market and spinal surgical navigation market. The MedSuite is a compilation of all reports related to a specific market. It is ideal for device manufacturers, product managers, marketing managers, and consultants looking for a detailed analysis of every market segment and sub-segment within a given market.

iData’s U.S. vascular access MedSuite covers 15 markets including implantable ports, needles, and syringes. The MedSuite is a compilation of all reports related to a specific market. It is ideal for device manufacturers, product managers, marketing managers, and consultants looking for a detailed analysis of every market segment and sub-segment within a given market.

iData’s U.S. gastrointestinal endoscopic devices MedSuite covers 11 markets including the enteral feeding devices market, and hemostasis devices market. The MedSuite is a compilation of all reports related to a specific market. It is ideal for device manufacturers, product managers, marketing managers, and consultants looking for a detailed analysis of every market segment and sub-segment within a given market.

The Infusion Therapy Device Market in the United States had a valuation of $3.0 billion in 2022. With a projected compound annual growth rate (CAGR) of 2.5%, it is estimated to surpass $3.6 billion by the end of the forecast period. Throughout this medical market research, we analyzed over 40 Infusion Therapy companies across the

The full report suite on the U.S. market for dental materials includes dental cements, dental impression materials, direct restorative materials, temporary restorative materials, dental bonding agents, dental core build-up materials and dental anesthetics.

iData’s U.S. operating room equipment MedSuite covers 10 markets including the hybrid and integrated operating room and surgical microscope markets. The MedSuite is a compilation of all reports related to a specific market. It is ideal for device manufacturers, product managers, marketing managers, and consultants looking for a detailed analysis of every market segment and sub-segment within a given market.

iData’s U.S. video endoscopy MedSuite covers 6 markets including the surgical camera systems market. The MedSuite is a compilation of all reports related to a specific market. It is ideal for device manufacturers, product managers, marketing managers, and consultants looking for a detailed analysis of every market segment and sub-segment within a given market.

In 2019, the U.S. dental imaging market size was valued at $796 million, with the Cone Beam Computed Tomography market seeing the fastest growth. The U.S. market is forecasted to increase over the forecast period and reach $823 million in 2025. Both intraoral and extraoral X-rays with digital technology are rapidly penetrating the market and

iData’s U.S. patient monitoring MedSuite covers 13 markets including fetal and neonatal monitoring, and pulse oximetry monitoring. The MedSuite is a compilation of all reports related to a specific market. It is ideal for device manufacturers, product managers, marketing managers, and consultants looking for a detailed analysis of every market segment and sub-segment within a given market.

Throughout this medical market research on the U.S. and European diabetes monitoring, treatment, and drug delivery markets, over 90 companies across 16 countries were analyzed. To conduct this research, our comprehensive methodology was utilized to understand the market sizes, unit sales, company market shares, and to create accurate forecasts. Previously, the U.S. diabetes monitoring, treatment, and

The U.S. and European insulin markets include long-acting insulin, ultra-long-acting insulin, rapid-acting insulin, premixed insulin, and human insulin. Within both the U.S. and the European markets the largest segment was the long-acting insulin market, which accounted for over 37% of the total market value. The long-acting insulin market has experienced increased competition, due to the expiration

The U.S. and European insulin pump markets include durable pumps and patch pumps, which are further segmented to account for hardware and disposable components. Within both the U.S. and the European insulin pump markets, the largest segment was the durable pump market, which accounted for the majority of the total market value. Durable pumps account for

The U.S. diabetes monitoring, treatment, and drug delivery market, also referred to as the diabetes care market, includes blood glucose meters, blood glucose test strips, lancets, continuous glucose monitoring (CGM), flash glucose monitoring (FGM), insulin, insulin pens, insulin syringes, and insulin pumps. Previously, the U.S. diabetes monitoring, treatment, and drug-delivery market was valued at $15.7